SEBI Reg. Investment Advisor

Download App

MoneyWorks4Me

Sun Pharma hikes stake in Zenotech Laboratories to 57.56%

28 Jul 2017 Evaluate

Sun Pharmaceutical Industries has raised its shareholding in Zenotech Laboratories from 46.85% of pre rights issue capital to 57.56% of the post rights issue capital.

This is pursuant to allotment of 1,90,00,000 equity shares of Rs 10 each for cash at a price of Rs 45 each including a share premium of Rs 35 per equity share issued on rights basis by Zenotech.

Sun Pharmaceutical Industries is the world’s fourth largest specialty generic pharmaceutical company and India’s top pharmaceutical company.


Sun Pharma Inds. Share Price

1881.70 34.40 (1.86%)
11-May-2026 11:11 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1881.70
Dr. Reddys Lab 1288.20
Cipla 1340.70
Zydus Lifesciences 943.75
Lupin 2252.80
View more..

About MoneyWorks4Me

MoneyWorks4Me is a SEBI-registered Investment Adviser (IA) dedicated to helping investors build long-term wealth through transparent, research-driven, conflict-free guidance. Founded in 2008, we started our journey as a Research Analyst (RA), providing deep fundamental analysis, intrinsic value insights, and long-term investing frameworks for Indian equities. In 2017, we transitioned to a full-fledged SEBI-registered Investment Adviser, strengthening our commitment to acting as a fiduciary—always putting the investor’s interest first.

Our Vision

To become India’s most trusted, research-powered fiduciary advisory platform—where every investor, regardless of experience, can make calm, confident, and well-reasoned investment decisions.

What Makes MoneyWorks4Me Different

Our Approach: Ensuring compounding work its magic on client portfolio.

MoneyWorks4Me ensures this through:

×